000			02799nam a22003377a 4500
003			OSt
005			20240305192319.0
008			220131b |||||||| |||| 00| 0 eng d
020			_a 9781451114249
020			_a1451114249
040			_cData centre
050			_aWH 39
082			_223 _a616.1’5
100			_a Amanda F. Cashen _930110
245			_aThe Washington Manual of Hematology and Oncology Subspecialty Consult
250			_aillustrated
260			_aLondon _b Lippincott Williams & Wilkins _c2012
300			_a 474 pages
490			_aWashington manual subspecialty consult series
520			_aThe Washington Manual Subspecialty Consult Series is designed to provide quick access to the essential information needed to evaluate a patient on a subspecialty consult service. The Washington Manual of Hematology and Oncology subspecialty consult has been completely reviewed, revised, and follows the bulleted format and template of The Washington Manual of Medical Therapeutics, 33/e to allow for quick,readily accessible information. This edition has been updated to include new standards in the treatment of malignancies and hematologic disorders, mechanisms of action of new therapeutic agents, and the current use of molecular prognostic factors. The information in each chapter is now presented in a consistent format, with important references cited. The Manual is a practical reference for fellows, residents, and medical students rotating on hematology and oncology subspecialty services. Most of the authors are hematology-oncology fellows or internal medicine residents, the physicians who have recent experience with the issues and questions that arise in the course of training in these subspecialties. Primary care practitioners and other health care professionals also will find this manual useful as a quick reference source in hematology and oncology. Features include: New, templated format same as The Washington University Medical Therapeutics, 33e Contains synopsis of symptoms, signs, and problems encountered in their daily workflow in a bulleted format for quick salient points Includes new standards in the treatment of malignancies and hematologic disorders, mechanisms of action of new therapeutic agents, and the current use of molecular prognostic factors
600			_x Medical / Oncology _929196
600			_x Medical / Internal Medicine _926949
600			_x Medical / Hematology _927137
600			_x Medical › Hematology _929097
600			_x Hematologic Diseases—Handbooks. _930111
600			_xDiagnosis, Differential —H andbooks. _930112
600			_xDrug Therapy—methods—Handbooks. _930113
600			_x Neoplasms— Handbooks. _930114
700			_a Brian Van Tine _930115
942			_2ddc _cEB
999			_c4648 _d4648